CCL2 and diabetic kidney disease: Transplantation of MSCs (mesenchymal stromal cells) into rats with diabetic nephropathy significantly reduced the levels of CD103+CDC1s, while decreasing the expression of inflammatory factors TNF-alpha and MCP-1, which in turn attenuated renal injury through the inactivation of CD8+ T cells3.